These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3161444)
1. [The complement system in hepatopathies]. De la Tour B; Kazatchkine M Ann Med Interne (Paris); 1985; 136(3):222-4. PubMed ID: 3161444 [TBL] [Abstract][Full Text] [Related]
2. Complement activation in chronic liver disease. Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631 [TBL] [Abstract][Full Text] [Related]
3. Genetics and biosynthesis of complement proteins. Colten HR; Alper CA; Rosen FS N Engl J Med; 1981 Mar; 304(11):653-6. PubMed ID: 6450325 [No Abstract] [Full Text] [Related]
8. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65. Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193 [TBL] [Abstract][Full Text] [Related]
9. Meningococcemia and acquired complement deficiency. Association in patients with hepatic failure. Ellison RT; Mason SR; Kohler PF; Curd JG; Reller LB Arch Intern Med; 1986 Aug; 146(8):1539-40. PubMed ID: 3729633 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum complement in chronic liver diseases and in acute hepatic insufficiency]. Naccarato R; Farini R; Chiaramonte M; Meani A; Giordano C; Gritti G Minerva Gastroenterol; 1976; 22(3):213-8. PubMed ID: 1004756 [No Abstract] [Full Text] [Related]
11. The human alternative complement pathway: biology and immunopathology of activation and regulation. Kazatchkine MD; Nydegger UE Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132 [No Abstract] [Full Text] [Related]
12. DNCB sensitivity in healthy Pakistani subjects and patients with liver disease. Zuberi SJ; Siddiqui M; Ahmed SA; Kara RY Pahlavi Med J; 1978 Jan; 9(1):14-20. PubMed ID: 652381 [TBL] [Abstract][Full Text] [Related]
14. The complement system in liver diseases. Qin X; Gao B Cell Mol Immunol; 2006 Oct; 3(5):333-40. PubMed ID: 17092430 [TBL] [Abstract][Full Text] [Related]
15. Impaired opsonization by serum from patients with chronic liver disease. Wyke RJ; Rajkovic IA; Williams R Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126 [TBL] [Abstract][Full Text] [Related]
16. [Behavior of complement activity in chronic liver disease]. Di Simone A; Coraggio F; Riegler G; Ciotola R Minerva Dietol Gastroenterol; 1977; 23(3):137-44. PubMed ID: 618090 [No Abstract] [Full Text] [Related]
17. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system. Teisberg P; Gjone E Clin Exp Immunol; 1973 Aug; 14(4):509-14. PubMed ID: 4201114 [TBL] [Abstract][Full Text] [Related]
18. Immunobiology and clinical importance of the complement system of man. Spitzer RE Adv Pediatr; 1977; 24():43-101. PubMed ID: 341668 [No Abstract] [Full Text] [Related]
19. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes. Arnaout MA; Luscinskas FW; Lionetti FJ; Alper CA; Valeri CR J Immunol; 1981 Jul; 127(1):278-81. PubMed ID: 6787126 [TBL] [Abstract][Full Text] [Related]
20. Increased level of the complement C3 protein in endogenous hypertriglyceridemia. Uza G; Cristea A; Cucuianu MP J Clin Lab Immunol; 1982 Jun; 8(2):101-5. PubMed ID: 7108936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]